The study represents a significant breakthrough in understanding the potential for reversing and measuring epigenetic changes associated with coronary heart disease after therapeutic intervention
. | June 13, 2023
Cardio Diagnostics Holdings, Inc , an artificial intelligence-powered precision cardiovascular medicine company, today announced a strategic engagement with Lifespan.io, a leading nonprofit advocacy. | April 5, 2023
Cardio Diagnostics Holdings, Inc today announced that it is sponsoring Becker’s Hospital Review 13th Annual Meeting. The conference is taking place next week, April 3-6, 2023, at the Hyatt. | March 29, 2023
Cardio Diagnostics Holdings Inc , an artificial intelligence-powered precision cardiovascular medicine company, today announced that China’s Patent Office has issued a Notice of Allowance to. | March 2, 2023